Equities
Health CareHealth Care Providers
  • Price (USD)215.48
  • Today's Change0.68 / 0.32%
  • Shares traded894.42k
  • 1 Year change+3.50%
  • Beta0.8112
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 17-Sep-24
Select bar for recommendation details.
Recommendations17-Sep-24
Buy8
Outperform10
Hold10
Sell1
Strong Sell0

Share price forecast in USD

The 25 analysts offering 12 month price targets for Veeva Systems Inc have a median target of 235.80, with a high estimate of 281.00 and a low estimate of 173.00. The median estimate represents a 9.43% increase from the last price of 215.48.
High30.4%281.00
Med9.4%235.80
Low-19.7%173.00

Earnings history & estimates in USD

On Aug 28, 2024, Veeva Systems Inc reported 2nd quarter 2025 earnings of 1.62 per share. This result exceeded the 1.53 consensus of the 22 analysts covering the company and exceeded last year's 2nd quarter results by 33.88%.
The next earnings announcement is expected on Dec 04, 2024.
Average growth rate+7.61%
Veeva Systems Inc reported annual 2024 earnings of 4.84 per share on Feb 29, 2024.
Average growth rate+22.24%
More ▼

Revenue history & estimates in USD

Veeva Systems Inc. had 2nd quarter 2025 revenues of 676.18m. This bettered the 668.38m consensus of the 23 analysts covering the company. This was 28.47% above the prior year's 2nd quarter results.
Average growth rate+3.46%
Veeva Systems Inc. had revenues for the full year 2024 of 2.36bn. This was 9.68% above the prior year's results.
Average growth rate+21.29%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.